Cargando…

Engineering NAD(+) availability for Escherichia coli whole-cell biocatalysis: a case study for dihydroxyacetone production

BACKGROUND: Whole-cell redox biocatalysis has been intensively explored for the production of valuable compounds because excellent selectivity is routinely achieved. Although the cellular cofactor level, redox state and the corresponding enzymatic activity are expected to have major effects on the p...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Yongjin J, Yang, Wei, Wang, Lei, Zhu, Zhiwei, Zhang, Sufang, Zhao, Zongbao K
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3831814/
https://www.ncbi.nlm.nih.gov/pubmed/24209782
http://dx.doi.org/10.1186/1475-2859-12-103
_version_ 1782291621813944320
author Zhou, Yongjin J
Yang, Wei
Wang, Lei
Zhu, Zhiwei
Zhang, Sufang
Zhao, Zongbao K
author_facet Zhou, Yongjin J
Yang, Wei
Wang, Lei
Zhu, Zhiwei
Zhang, Sufang
Zhao, Zongbao K
author_sort Zhou, Yongjin J
collection PubMed
description BACKGROUND: Whole-cell redox biocatalysis has been intensively explored for the production of valuable compounds because excellent selectivity is routinely achieved. Although the cellular cofactor level, redox state and the corresponding enzymatic activity are expected to have major effects on the performance of the biocatalysts, our ability remains limited to predict the outcome upon variation of those factors as well as the relationship among them. RESULTS: In order to investigate the effects of cofactor availability on whole-cell redox biocatalysis, we devised recombinant Escherichia coli strains for the production of dihydroxyacetone (DHA) catalyzed by the NAD(+)-dependent glycerol dehydrogenase (GldA). In this model system, a water-forming NAD(+) oxidase (NOX) and a NAD(+) transporter (NTT4) were also co-expressed for cofactor regeneration and extracellular NAD(+) uptake, respectively. We found that cellular cofactor level, NAD(+)/NADH ratio and NOX activity were not only strain-dependent, but also growth condition-dependent, leading to significant differences in specific DHA titer among different whole-cell biocatalysts. The host E. coli DH5α had the highest DHA specific titer of 0.81 g/g(DCW) with the highest NAD(+)/NADH ratio of 6.7 and NOX activity of 3900 U. The biocatalyst had a higher activity when induced with IPTG at 37°C for 8 h compared with those at 30°C for 8 h and 18 h. When cells were transformed with the ntt4 gene, feeding NAD(+) during the cell culture stage increased cellular NAD(H) level by 1.44 fold and DHA specific titer by 1.58 fold to 2.13 g/g(DCW). Supplementing NAD(+) during the biotransformation stage was also beneficial to cellular NAD(H) level and DHA production, and the highest DHA productivity reached 0.76 g/g(DCW)/h. Cellular NAD(H) level, NAD(+)/NADH ratio, and NOX and GldA activity dropped over time during the biotransformation process. CONCLUSIONS: High NAD(+)/NADH ratio driving by NOX was very important for DHA production. Once cofactor was efficiently cycled, high cellular NAD(H) level was also beneficial for whole-cell redox biocatalysis. Our results indicated that NAD(+) transporter could be applied to manipulate redox cofactor level for biocatalysis. Moreover, we suggested that genetically designed redox transformation should be carefully profiled for further optimizing whole-cell biocatalysis.
format Online
Article
Text
id pubmed-3831814
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-38318142013-11-19 Engineering NAD(+) availability for Escherichia coli whole-cell biocatalysis: a case study for dihydroxyacetone production Zhou, Yongjin J Yang, Wei Wang, Lei Zhu, Zhiwei Zhang, Sufang Zhao, Zongbao K Microb Cell Fact Research BACKGROUND: Whole-cell redox biocatalysis has been intensively explored for the production of valuable compounds because excellent selectivity is routinely achieved. Although the cellular cofactor level, redox state and the corresponding enzymatic activity are expected to have major effects on the performance of the biocatalysts, our ability remains limited to predict the outcome upon variation of those factors as well as the relationship among them. RESULTS: In order to investigate the effects of cofactor availability on whole-cell redox biocatalysis, we devised recombinant Escherichia coli strains for the production of dihydroxyacetone (DHA) catalyzed by the NAD(+)-dependent glycerol dehydrogenase (GldA). In this model system, a water-forming NAD(+) oxidase (NOX) and a NAD(+) transporter (NTT4) were also co-expressed for cofactor regeneration and extracellular NAD(+) uptake, respectively. We found that cellular cofactor level, NAD(+)/NADH ratio and NOX activity were not only strain-dependent, but also growth condition-dependent, leading to significant differences in specific DHA titer among different whole-cell biocatalysts. The host E. coli DH5α had the highest DHA specific titer of 0.81 g/g(DCW) with the highest NAD(+)/NADH ratio of 6.7 and NOX activity of 3900 U. The biocatalyst had a higher activity when induced with IPTG at 37°C for 8 h compared with those at 30°C for 8 h and 18 h. When cells were transformed with the ntt4 gene, feeding NAD(+) during the cell culture stage increased cellular NAD(H) level by 1.44 fold and DHA specific titer by 1.58 fold to 2.13 g/g(DCW). Supplementing NAD(+) during the biotransformation stage was also beneficial to cellular NAD(H) level and DHA production, and the highest DHA productivity reached 0.76 g/g(DCW)/h. Cellular NAD(H) level, NAD(+)/NADH ratio, and NOX and GldA activity dropped over time during the biotransformation process. CONCLUSIONS: High NAD(+)/NADH ratio driving by NOX was very important for DHA production. Once cofactor was efficiently cycled, high cellular NAD(H) level was also beneficial for whole-cell redox biocatalysis. Our results indicated that NAD(+) transporter could be applied to manipulate redox cofactor level for biocatalysis. Moreover, we suggested that genetically designed redox transformation should be carefully profiled for further optimizing whole-cell biocatalysis. BioMed Central 2013-11-09 /pmc/articles/PMC3831814/ /pubmed/24209782 http://dx.doi.org/10.1186/1475-2859-12-103 Text en Copyright © 2013 Zhou et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Zhou, Yongjin J
Yang, Wei
Wang, Lei
Zhu, Zhiwei
Zhang, Sufang
Zhao, Zongbao K
Engineering NAD(+) availability for Escherichia coli whole-cell biocatalysis: a case study for dihydroxyacetone production
title Engineering NAD(+) availability for Escherichia coli whole-cell biocatalysis: a case study for dihydroxyacetone production
title_full Engineering NAD(+) availability for Escherichia coli whole-cell biocatalysis: a case study for dihydroxyacetone production
title_fullStr Engineering NAD(+) availability for Escherichia coli whole-cell biocatalysis: a case study for dihydroxyacetone production
title_full_unstemmed Engineering NAD(+) availability for Escherichia coli whole-cell biocatalysis: a case study for dihydroxyacetone production
title_short Engineering NAD(+) availability for Escherichia coli whole-cell biocatalysis: a case study for dihydroxyacetone production
title_sort engineering nad(+) availability for escherichia coli whole-cell biocatalysis: a case study for dihydroxyacetone production
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3831814/
https://www.ncbi.nlm.nih.gov/pubmed/24209782
http://dx.doi.org/10.1186/1475-2859-12-103
work_keys_str_mv AT zhouyongjinj engineeringnadavailabilityforescherichiacoliwholecellbiocatalysisacasestudyfordihydroxyacetoneproduction
AT yangwei engineeringnadavailabilityforescherichiacoliwholecellbiocatalysisacasestudyfordihydroxyacetoneproduction
AT wanglei engineeringnadavailabilityforescherichiacoliwholecellbiocatalysisacasestudyfordihydroxyacetoneproduction
AT zhuzhiwei engineeringnadavailabilityforescherichiacoliwholecellbiocatalysisacasestudyfordihydroxyacetoneproduction
AT zhangsufang engineeringnadavailabilityforescherichiacoliwholecellbiocatalysisacasestudyfordihydroxyacetoneproduction
AT zhaozongbaok engineeringnadavailabilityforescherichiacoliwholecellbiocatalysisacasestudyfordihydroxyacetoneproduction